Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Hironori, Ninomiya"'
Autor:
Hironori Ninomiya, Yukiko Sato, Kentaro Inamura, Akito Dobashi, Kengo Takeuchi, Hiroki Mitani, Mingyon Mun, Makoto Nishio, Yuichi Ishikawa
Publikováno v:
Diagnostic Pathology, Vol 19, Iss 1, Pp 1-12 (2024)
Abstract Introduction NUT carcinoma is a rare cancer associated with a poor prognosis. Because of its rarity, its diagnosis is challenging and is usually made by excluding other diagnoses. Immunohistochemical analysis is a reliable technique that con
Externí odkaz:
https://doaj.org/article/7d6547d3cafb4ea18f0277d57cb2f443
Autor:
Yoshiaki Amino, Siew‐Kee Low, Hironori Ninomiya, Ayu Kiritani, Keiki Miyadera, Sho Kakuto, Takahiro Akita, Ryosuke Tsugitomi, Ryo Ariyasu, Ken Uchibori, Satoru Kitazono, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 14, Iss 33, Pp 3317-3322 (2023)
Abstract Background KRAS mutation positive lung cancer is known to be clinically characterized by older age, males, and smokers. It is reported to be more common in mucinous adenocarcinoma, but all reports are based on analysis of tissue samples. Rec
Externí odkaz:
https://doaj.org/article/65050a39348140f4a87a937f35d99782
Publikováno v:
Cancer Treatment and Research Communications, Vol 39, Iss , Pp 100814- (2024)
Background: Large amino acid transporter type 1 (LAT1) provides cancer cells with essential amino acids for both protein synthesis and cell growth and may predict patient prognosis. Additionally, LAT1 inhibition can be a therapeutic target. This stud
Externí odkaz:
https://doaj.org/article/fa7669b2a5f74bc3ab3e8b4c3b4757e4
Autor:
Takahiro Yoshizawa, Ken Uchibori, Mitsugu Araki, Shigeyuki Matsumoto, Biao Ma, Ryo Kanada, Yosuke Seto, Tomoko Oh-hara, Sumie Koike, Ryo Ariyasu, Satoru Kitazono, Hironori Ninomiya, Kengo Takeuchi, Noriko Yanagitani, Satoshi Takagi, Kazuma Kishi, Naoya Fujita, Yasushi Okuno, Makoto Nishio, Ryohei Katayama
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-11 (2021)
Abstract Approximately 15–30% of patients with lung cancer harbor mutations in the EGFR gene. Major EGFR mutations (>90% of EGFR-mutated lung cancer) are highly sensitive to EGFR tyrosine kinase inhibitors (TKIs). Many uncommon EGFR mutations have
Externí odkaz:
https://doaj.org/article/c1c4f342481c4dad8da1ff3a202ae813
Autor:
Shoko Ueda, Takehito Shukuya, Takuo Hayashi, Mario Suzuki, Akihide Kondo, Yuta Arai, Tomohito Takeshige, Hironori Ninomiya, Kazuhisa Takahashi
Publikováno v:
Thoracic Cancer, Vol 12, Iss 5, Pp 715-719 (2021)
Abstract To date, several studies have described the mechanism of resistance to first‐ or second‐generation anaplastic lymphoma kinase (ALK) inhibitors. Secondary ALK mutations, ALK gene amplification, and other bypass signal activations (i.e., K
Externí odkaz:
https://doaj.org/article/6062030a7e4a4985952926928c893f1d
Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice
Autor:
Ryo Ariyasu, Ken Uchibori, Hironori Ninomiya, Shinsuke Ogusu, Ryosuke Tsugitomi, Ryo Manabe, Hiroaki Sakamaoto, Takehiro Tozuka, Hiroshi Yoshida, Yoshiaki Amino, Satoru Kitazono, Noriko Yanagitani, Kengo Takeuchi, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 12, Iss 4, Pp 504-511 (2021)
Abstract Background The usefulness of the Oncomine Dx Target test (Oncomine Dx), a next‐generation sequencing (NGS) test, has already been proven in clinical trials. However, NGS requires high‐quality tumor samples and takes a long time to genera
Externí odkaz:
https://doaj.org/article/7b7ef5a8795d4eb2b4b8ec0478f05a2a
Autor:
Hikaru Watanabe, Katsunori Oikado, Yoshinao Sato, Ryota Ichikawa, Hironori Ninomiya, Mingyon Mun, Masayuki Nakao, Yosuke Matsuura, Junji Ichinose, Takashi Terauchi
Publikováno v:
Journal of Thoracic Imaging; Nov2024, Vol. 39 Issue 6, pW108-W110, 3p
Characteristics of surgically resected non‐small cell lung cancer patients with post‐recurrence cure
Autor:
Dai Sonoda, Yosuke Matsuura, Yasuto Kondo, Junji Ichinose, Masayuki Nakao, Hironori Ninomiya, Yuichi Ishikawa, Makoto Nishio, Sakae Okumura, Yukitoshi Satoh, Mingyon Mun
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3280-3288 (2020)
Background The prognosis of postoperative recurrence in patients with non‐small cell lung cancer (NSCLC) is poor. However, depending on the recurrence patterns and treatment options, some patients can achieve long‐term survival following recurren
Externí odkaz:
https://doaj.org/article/a71e6e9908e64f0eaded6f938adeef16
Autor:
Naoya Iwamoto, Yosuke Matsuura, Hironori Ninomiya, Junji Ichinose, Masayuki Nakao, Yuichi Ishikawa, Sakae Okumura, Mingyon Mun
Publikováno v:
Surgical Case Reports, Vol 6, Iss 1, Pp 1-5 (2020)
Abstract Background Liposarcoma arising from the mediastinum is rare, accounting for less than 1% of mediastinal tumors. Furthermore, a rapidly growing well-differentiated liposarcoma is extremely rare. A well-differentiated liposarcoma is usually co
Externí odkaz:
https://doaj.org/article/a960cfbd589844df8265e645035cbbfa
Autor:
Hironori Ninomiya, MD, PhD, Kentaro Inamura, MD, PhD, Mingyon Mun, MD, PhD, Makoto Nishio, MD, PhD, Yuichi Ishikawa, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 4, Pp 100293- (2022)
Introduction: The eight TNM classification of lung tumors provides a more precise prediction of prognosis than previous classification systems, especially in T1 tumors, the invasion size of which are less than or equal to 3 cm. T1 is divided into T1a
Externí odkaz:
https://doaj.org/article/97ae50169b314c70be4259b944791647